Intercept Pharmaceuticals ICPT reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Intercept Pharmaceuticals missed estimated earnings by 525.0%, reporting an EPS of $-0.25 versus an estimate of $-0.04.
Revenue was down $24.82 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.32 which was followed by a 1.63% drop in the share price the next day.
Here's a look at Intercept Pharmaceuticals's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.